Hypermarcas (OTCMKTS:HYPMY) Shares Gap Down – Here’s Why

Hypermarcas (OTCMKTS:HYPMY)’s share price gapped down before the market opened on Monday . The stock had previously closed at $4.17, but opened at $3.97. Hypermarcas shares last traded at $3.97, with a volume of 155 shares traded.

Analysts Set New Price Targets

Separately, Zacks Research upgraded shares of Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy”.

Hypermarcas Stock Down 2.8%

The firm’s fifty day simple moving average is $4.33 and its 200-day simple moving average is $4.40. The company has a market cap of $2.85 billion, a PE ratio of 8.45 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMY) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 earnings per share for the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. The business had revenue of $383.13 million during the quarter. On average, analysts predict that Hypermarcas will post 0.53 earnings per share for the current year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.